Effectiveness of arginase inhibitors against experimentally induced stroke
Authors:
- 29 March 2018
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 391 (6) , 603-612
Abstract
Stroke is a lethal disease, but it disables more than it kills. Stroke is the second leading cause of death and the most frequent cause of permanent disability in adults worldwide, with 90% of survivors having residual deficits. The pathophysiology of stroke is complex and involves a strong inflammatory response associated with oxidative stress and activation of several proteolytic enzymes. The current study was designed to investigate the effect of arginase inhibitors (L-citruline and L-ornithine) against ischemic stroke induced in rats by middle cerebral artery occlusion (MCAO). MCAO resulted in alteration in rat behavior, brain infarct, and edema associated with disruption of the blood-brain barrier (BBB). This was mediated through overexpression of arginase I and II, inducible NOS (iNOS), malondialdehyde (MDA), advanced glycation end products (AGEs), TNF-α, and IL-1β and downregulation of endothelial nitric oxide synthase (eNOS). Treatment with L-citruline and L-ornithine and the standard neuroprotective drug cerebrolysin ameliorated all the deleterious effects of stroke. These results indicate the possible use of arginase inhibitors in the treatment of stroke after suitable clinical trials are done.Keywords
Funding Information
- University of Tabuk (S-1438-0096)
This publication has 80 references indexed in Scilit:
- Neuroprotection after cerebral ischemiaAnnals of the New York Academy of Sciences, 2013
- Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistribution in human umbilical vein endotheliumPlacenta, 2011
- Nitric oxide synthases: regulation and functionEuropean Heart Journal, 2011
- The immunology of stroke: from mechanisms to translationNature Medicine, 2011
- Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood–brain barrier in a mice hemorrhage modelJournal of Neuroscience Methods, 2011
- Reference genes for normalising gene expression data in collagenase-induced rat intracerebral haemorrhageBMC Molecular Biology, 2010
- Vascular dysfunction in retinopathy—An emerging role for arginaseBrain Research Bulletin, 2009
- Diabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase ActivityCirculation Research, 2008
- Arginase Modulates NF-κB Activity via a Nitric Oxide–Dependent MechanismAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTIONClinical and Experimental Pharmacology and Physiology, 2007